4523.T - Eisai Co Ltd
JPMorganEstimate Revision, Price Target Increase
Eisai (4523) Focus on FY2026 operating profit level in near term, approval of Leqembi subcutaneous injection as initial therapy and its market penetration thereafter
公司
4523.T
日期
2026-03-17
分析师
Mr. Seiji Wakao
页数
23 页
需要登录
请登录后购买研报或生成音频内容。